Author

S. L. Woods

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Assay:metagenomics· 1

Frequent Co-Authors

D. L. Worthley· 2 shared G. Radford· 2 shared H. Kobayashi· 2 shared J. Q. Ng· 2 shared L. Vrbanac· 2 shared T. Wang· 2 shared A. A. Saleh· 1 shared A. Ali· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

D. L. Worthley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Colorectal cancer detection and treatment with engineered probiotics

C. R. Gurbatri, G. Radford, L. Vrbanac, C. Coker, J. Im, S. R. Taylor, Y. Jang, A. Sivan, K. Rhee, A. A. Saleh, T. Chien, F. Zandkarimi, I. Lia, T. R. Lannagan, T. Wang, , T. Danino

This paper demonstrates the use of engineered probiotics to detect and treat colorectal cancer by monitoring their colonization and delivering therapeutic molecules.

bioRxiv · Apr 3, 2023 · PreprintBioengineering

Loss of Grem1-articular cartilage progenitor cells causes osteoarthritis.

J. Q. Ng, T. H. Jafarov, C. B. Little, T. Wang, A. Ali, Y. Ma, G. Radford, L. Vrbanac, M. Ichinose, S. Whittle, D. Hunter, T. Lannagan, N. Suzuki, J. M. Goyne, H. Kobayashi, , S. Mukherjee

This study identifies Grem1-articular cartilage progenitor cells as critical for maintaining joint health, and their loss leads to osteoarthritis, with potential therapeutic targeting of FGFR3.

bioRxiv · Mar 29, 2023 · PreprintCell Biology